Benitec Biopharma Inc. (BNTC) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$41.77M | -85.7% |
| 2024 | -$22.49M | -17.9% |
| 2023 | -$19.08M | -6.9% |
| 2022 | -$17.85M | -31.3% |
| 2021 | -$13.60M | -64.2% |
| 2020 | -$8.28M | -420.6% |
| 2019 | $2.58M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$41.77M | -85.7% |
| 2024 | -$22.49M | -17.9% |
| 2023 | -$19.08M | -6.9% |
| 2022 | -$17.85M | -31.3% |
| 2021 | -$13.60M | -64.2% |
| 2020 | -$8.28M | -420.6% |
| 2019 | $2.58M | — |